Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Effik is a specialized pharmaceutical company focused exclusively on women's health, covering areas such as contraception, menopause, fertility, and pregnancy. Founded in 1992 and headquartered in France, the company was acquired by the Italian Italfarmaco Group in 2005, which facilitated its expansion across major European markets. Effik provides a comprehensive portfolio of prescription medicines, medical devices, and food supplements designed to meet the specific physiological needs of women throughout different life stages. Its well-known brands, such as Natalben and various hormonal treatments, are widely distributed in countries including France, Spain, Portugal, and Italy. The company maintains a strong presence in the gynecological community through specialized product development and medical education.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratórios EFFIK.